| Stage | HLIO | % of rev | CWST | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $232M | 100.00% | $544M | 100.00% | CWST ×2.34 |
| Gross profit | $80M | 34.58% | $179M | 32.88% | HLIO +1.7pp |
| Operating income | $33M | 14.01% | $20M | 3.67% | HLIO +10.3pp |
| Pre-tax income | $28M | 12.12% | $3M | 0.62% | HLIO +11.5pp |
| Net income | $22M | 9.44% | $4M | 0.69% | HLIO +8.8pp |
| Stage | HLIO | CWST | Gap · A − B |
|---|---|---|---|
| Revenue | $232M100.00% | $544M100.00% | CWST ×2.34 |
| Gross profit | 34.58%$80M | 32.88%$179M | HLIO +1.7pp |
| Operating income | 14.01%$33M | 3.67%$20M | HLIO +10.3pp |
| Pre-tax income | 12.12%$28M | 0.62%$3M | HLIO +11.5pp |
| Net income |
| 9.44%$22M |
| 0.69%$4M |
| HLIO +8.8pp |
None
No disclosed counterparties: HLIO.